COVID-19: No Vaccine had been approved by NAFDAC — DG

Director- General for National Agency for Food and Drug Administration Control (NAFDAC),  Prof. Mojisola Adeyeye, says no vaccine had been approved yet.

 

 

She proclaimed this statement in Abuja on Friday.

 

Making it known to general public that the agency had not received any application from vaccine manufacturers “and therefore, no vaccine had been approved by NAFDAC.

 

“There are several reports of fake vaccines in Nigeria; NAFDAC is pleading with the general public to beware. COVID-19 vaccines are new, and the side effects must be monitored.

 

“No COVID-19 vaccines have been approved by NAFDAC. Fake vaccines can cause COVID-like illnesses or other serious diseases that can spread and killnin no time.’’

The director-general, who reiterate the commitment of the agency toward guaranteeing drugs security, warned companies and corporate bodies against unapproved brought in of vaccines, citing that genuine manufacturing companies had to submit applications to NAFDAC first before they can took any further action especially on vaccine distribution.

 

 

“No government establishment or agencies should order for COVID-19 vaccines without confirming from NAFDAC.

 

“However, NAFDAC is discussing with manufacturers of candidate COVID-19 vaccines concerning potential Emergency Use Authorisation (EUA),

 

registration or licencing of their products as the case may be.”

 

Adeyeye, however, assured applicants of NAFDAC’s determination to approve vaccines for emergency use if phase three clinical data were convincing and robust

 

with regards to safety and efficacy, and the vaccine had been submitted for the World Health Organisation  (WHO) emergency use listing.

 

She emphasised the commitment of NAFDAC in using “Reliance” or “Recognition” to expedite Emergency Use Authorisation (EUA) for vaccines already approved by mature regulatory authorities.

 

“The full dossiers submitted by the manufacturer or Market Authorisation Holder (MAH) will be thoroughly reviewed by the Vaccine Committee that is made up of multiple directorates in the agency.”

 

The NAFDAC boss, who said that the agency would welcome the application for Emergency Use Authorisation in Nigeria, however, reiterated readiness to examine the safety of any vaccine.

 

She affirmed the collaboration of NAFDAC with sister agencies as the National Primary Health Care Development Agency (NPHCDA), Nigeria Centre for Disease Control (NCDC), UNICEF,

 

 

WHO and the Ministry of Health, aimed at achieving a holistic approach for effective immunisation and delivery.

 

“NAFDAC plans to also use Traceability with GS1 Technology to monitor vaccine distribution, using Global Trade Item Number (GTIN).

 

“The goal is to prevent fake vaccines from infiltrating the supply chain and to ensure there is no diversion.

 

“This effort will create a reliable and predictable supply chain. The multi-stakeholder technical working group has been meeting to address different issues from

 

 

access to distribution to traceability to the monitoring of adverse events following immunisation.

 

“NAFDAC is also a member of Regulators Steering Committee of African Union -3S (Smart, Safety, Surveillance) with Ghana, South Africa and Ethiopia, collaborating

 

with UK Medicines Healthcare Products Regulatory Agency (MHRA) with funding from Bill and Melinda gates Foundation.

 

Adeyeye explained that the aim of the continental collaboration was to use COVID-19 vaccines distribution and immunisation as a pilot to actively monitor the

 

 

distribution, delivery and monitoring of Adverse Effects Following Immunisation at the continental level, aimed at creating an African-based vigilance system for the safety of medicines.

 

Source: Vanguard

 

 

 9,735 total views,  2 views today

Leave a Reply

Your email address will not be published.